Article, 2023

Serological biomarkers at hospital admission and hospitalization treatments are not related to the development of post-COVID dyspnea

European Journal of Internal Medicine, ISSN 1879-0828, 0953-6205, Volume 119, Pages 132-135, 10.1016/j.ejim.2023.11.004

Contributors

Fernández-De-Las-Peñas, César 0000-0003-3772-9690 [1] [2] Guijarro, Carlos 0000-0001-8132-9366 [2] [3] Velasco-Arribas, María 0000-0001-6554-2095 [2] [3] Pellicer-Valero, Oscar Jose 0000-0002-0104-1029 [4] Torres-Macho, Juan 0000-0002-8860-6837 [5] [6]

Affiliations

  1. [1] Aalborg University
    2. [NORA names: AAU Aalborg University; University; Denmark; Europe, EU; Nordic; OECD];
  2. [2] King Juan Carlos University
    3. [NORA names: Spain; Europe, EU; OECD];
  3. [3] Hospital Universitario Fundación Alcorcón
    4. [NORA names: Spain; Europe, EU; OECD];
  4. [4] University of Valencia
    5. [NORA names: Spain; Europe, EU; OECD];
  5. [5] Complutense University of Madrid
    6. [NORA names: Spain; Europe, EU; OECD];

Keywords

admission, biomarkers, development, dyspnea, hospital, hospital admission, hospital treatment, serological biomarkers, treatment

Funders

  • Comunidad de Madrid

Data Provider: Digital Science

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+